A Novel Humanized Model of NASH and Its Treatment With META4, A Potent Agonist of MET.
Cell Mol Gastroenterol Hepatol
; 13(2): 565-582, 2022.
Article
in En
| MEDLINE
| ID: mdl-34756982
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Non-alcoholic Fatty Liver Disease
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Cell Mol Gastroenterol Hepatol
Year:
2022
Document type:
Article
Country of publication: